Vir Biotechnology VIR
$8.39 −$0.48 (-5.41%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.30 -1.05%
Open$8.77
Prev close$8.87
Day range$8.34 – $8.92
Volume3.09M
Market cap$1.56B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue-$200,000.00-207.7% YoY
Operating profit-$104.66M+39.7% YoY
Net profit-$96.25M+41.0% YoY
Diluted EPS-$0.57+51.3% YoY
Free cash flow-$106.12M+36.8% YoY
Operating cash flow-$106.08M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin100.0%
Operating margin-69.9%
Net margin-61.1%
Return on equity-21.8%
Return on assets-17.3%
Return on invested capital-21.7%
Current ratio6.30
Liabilities / assets19.4%
Cash & investments$458.36M
Total debt$81.46M
Net cash (debt)$376.90M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | -$188,000.00 | $238.95M | -$29,000.00 | $68.56M | $64.07M |
| Total Operating Revenue | -$200,000.00 | $238.94M | -$41,000.00 | $66.52M | $63.76M |
| Cost of Revenue | $0.00 | $0.00 | – | $26,000.00 | $26,000.00 |
| Gross Profit | -$200,000.00 | $238.94M | – | $66.49M | $63.73M |
| Operating Expense | $104.46M | $165.47M | $132.25M | $546.00M | $111.66M |
| Selling and Admin Expenses | $24.43M | $30.20M | $23.34M | $92.07M | $23.62M |
| Research & Development | $80.04M | $135.28M | $108.92M | $455.97M | $88.35M |
| Other Operating Expenses | -$12,000.00 | -$11,000.00 | -$12,000.00 | -$2.04M | -$310,000.00 |
| Operating Profit | -$104.66M | $73.47M | -$132.29M | -$479.51M | -$47.92M |
| Net Non-Operating Interest Income (Expense) | $9.32M | $8.97M | $7.19M | $40.24M | $7.80M |
| Non-Operating Interest Income | $9.32M | $8.97M | $7.19M | $40.24M | $7.80M |
| Other Income (Expense) | -$1.06M | -$2.17M | -$424,000.00 | $1.50M | -$2.94M |
| Gain on Sale of Security | -$409,000.00 | -$1.72M | -$170,000.00 | $1.73M | -$2.61M |
| Special Income (Charges) | $0.00 | $0.00 | $0.00 | $182,000.00 | $0.00 |
| -Less:Restructuring and Mergern & Acquisition | $0.00 | $0.00 | $0.00 | -$182,000.00 | $0.00 |
| Other Non-Operating Income (Expenses) | -$651,000.00 | -$451,000.00 | -$254,000.00 | -$409,000.00 | -$335,000.00 |
| Pretax Profit | -$96.40M | $80.26M | -$125.53M | -$437.77M | -$43.06M |
| Tax | -$143,000.00 | $179,000.00 | $170,000.00 | $217,000.00 | -$137,000.00 |
| Net Profit | -$96.25M | $80.08M | -$125.70M | -$437.99M | -$42.92M |
| Profit from Continuing Operations | -$96.25M | $80.08M | -$125.70M | -$437.99M | -$42.92M |
| Net Income to Parent Company | -$96.25M | $80.08M | -$125.70M | -$437.99M | -$42.92M |
| Net Income to Common Stockholders | -$96.25M | $80.08M | -$125.70M | -$437.99M | -$42.92M |
| Basic EPS | -$0.57 | $0.48 | -$0.85 | -$3.16 | -$0.31 |
| Diluted EPS | -$0.57 | $0.47 | -$0.85 | -$3.16 | -$0.31 |
| Minority Interests | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.11B | $1.21B | $1.03B | $1.00B | $1.00B |
| Total Current Assets | $508.27M | $573.74M | $522.99M | $514.08M | $514.08M |
| Cash and Cash Equivalents & Short-Term Investments | $458.36M | $532.73M | $476.30M | $467.02M | $467.02M |
| -Cash and Cash Equivalents | $218.87M | $278.73M | $274.16M | $232.19M | $232.19M |
| -Short Term Investments | $239.49M | $254.00M | $202.14M | $234.83M | $234.83M |
| Restricted Cash | $1.93M | $1.93M | $1.93M | $1.92M | $1.92M |
| Other Current Assets | $47.98M | $39.08M | $44.76M | $45.14M | $45.14M |
| Total Non-Current Assets | $603.58M | $641.07M | $502.60M | $488.74M | $488.74M |
| Net PPE | $105.76M | $109.82M | $113.92M | $117.72M | $117.72M |
| -Gross PPE | $161.08M | $162.45M | $163.82M | $164.88M | $164.88M |
| -Accumulated Depreciation | -$55.32M | -$52.63M | -$49.90M | -$47.16M | -$47.16M |
| Investments and Advances | $442.93M | $475.02M | $332.97M | $314.58M | $314.58M |
| -Available for Sale Securities | $442.93M | $475.02M | $332.97M | $314.58M | $314.58M |
| Goodwill and Other Intangible Assets | $24.57M | $24.64M | $24.71M | $24.79M | $24.79M |
| -Goodwill | $16.94M | $16.94M | $16.94M | $16.94M | $16.94M |
| -Other Intangible Assets | $7.63M | $7.70M | $7.78M | $7.85M | $7.85M |
| Other Non-Current Assets | $30.32M | $31.59M | $31.00M | $31.66M | $31.66M |
| Total Liabilities | $215.82M | $232.31M | $212.82M | $237.55M | $237.55M |
| Total Current Liabilities | $80.66M | $94.96M | $73.56M | $92.82M | $92.82M |
| Payables | $13.16M | $19.59M | $7.27M | $11.63M | $11.63M |
| -Accounts Payable | $11.32M | $17.75M | $5.45M | $9.80M | $9.80M |
| -Other Payable | $1.84M | $1.83M | $1.83M | $1.83M | $1.83M |
| Current Accrued Expenses | $58.18M | $66.24M | $57.34M | $72.39M | $72.39M |
| Short-Term Debt and Capital Lease Obligation | $9.32M | $9.14M | $8.94M | $8.80M | $8.80M |
| -Current Capital Lease Obligation | $9.32M | $9.14M | $8.94M | $8.80M | $8.80M |
| Total Non-Current Liabilities | $135.16M | $137.35M | $139.26M | $144.73M | $144.73M |
| Long Term Debt and Capital Lease Obligation | $81.46M | $84.14M | $86.64M | $89.05M | $89.05M |
| -Long Term Capital Lease Obligation | $81.46M | $84.14M | $86.64M | $89.05M | $89.05M |
| Other Non-Current Liabilities | $53.70M | $53.22M | $52.63M | $55.68M | $55.68M |
| Total Equity | $896.04M | $982.49M | $812.77M | $765.28M | $765.28M |
| Stockholders' Equity | $896.04M | $982.49M | $812.77M | $765.28M | $765.28M |
| Capital Stock | $17,000.00 | $17,000.00 | $16,000.00 | $14,000.00 | $14,000.00 |
| -Common Stock | $17,000.00 | $17,000.00 | $16,000.00 | $14,000.00 | $14,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $2.24B | $2.23B | $2.14B | $1.97B | $1.97B |
| Retained Earnings | -$1.34B | -$1.24B | -$1.32B | -$1.20B | -$1.20B |
| Gains/Losses Not Affecting Retained Earnings | -$6.90M | -$4.60M | -$3.48M | -$2.06M | -$2.06M |
| Current Deferred Liabilities | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$106.08M | $123.33M | -$132.39M | -$391.78M | -$25.88M |
| Net cash flow from continuing operations | -$106.08M | $123.33M | -$132.39M | -$391.78M | -$25.88M |
| Net Income from Continuing Operations | -$96.25M | $80.08M | -$125.70M | -$437.99M | -$42.92M |
| Depreciation & Depletion & Amortization | $2.77M | $2.80M | $2.81M | $11.68M | $2.90M |
| Other Non-Cash Items | $198,000.00 | $2.42M | $530,000.00 | $156,000.00 | $1.63M |
| Change in Working Capital | -$22.80M | $23.47M | -$22.68M | -$22.45M | -$2.84M |
| -Change in Prepaid Assets | -$8.90M | $5.68M | $382,000.00 | $2.08M | -$8.08M |
| -Change in Payables and Accrued Expense | -$12.64M | $20.70M | -$21.45M | -$4.51M | $16.27M |
| -Change in Other Current Assets | $1.24M | -$604,000.00 | $657,000.00 | -$12.64M | -$8.72M |
| -Change in Other Current Liabilities | -$2.50M | -$2.31M | -$2.27M | -$7.37M | -$2.32M |
| Net cash flow from investing | $44.56M | -$197.14M | $11.84M | $310.37M | $86.65M |
| Net Cash Flow from Continuing Investing Activities | $44.56M | -$197.14M | $11.84M | $310.37M | $86.65M |
| Net PPE Purchase and Sale | -$34,000.00 | -$32,000.00 | -$390,000.00 | -$4.58M | -$458,000.00 |
| Net Investment Purchase and Sale | $44.59M | -$197.11M | $12.23M | $314.95M | $87.11M |
| Financing Cash Flow | $1.63M | $78.38M | $162.52M | $3.79M | $1.04M |
| Net Cash Flow from Continuing Financing Activities | $1.63M | $78.38M | $162.52M | $3.79M | $1.04M |
| Net Common Stock Issuance | $0.00 | $75.58M | $162.35M | – | – |
| Proceeds from Stock Option Exercised | $1.63M | $2.80M | $174,000.00 | $4.15M | $1.04M |
| Ending Cash Balance | $227.71M | $287.60M | $283.04M | $241.07M | $241.07M |
| Net Change in Cash | -$59.89M | $4.56M | $41.97M | -$77.63M | $61.81M |
| Beginning Cash Balance | $287.60M | $283.04M | $241.07M | $318.70M | $179.26M |
| Free Cash Flow | -$106.12M | $123.29M | -$132.78M | -$396.61M | -$26.22M |
| Net Other Financing Charges | – | – | – | -$361,000.00 | -$2,000.00 |
No comments yet — be the first to weigh in on VIR.
Sign in to join the discussion.